PLIANT THERAPEUTICS, INC. (PLRX) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Pliant Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Pliant Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$547 M, a 45.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$547 M -$171 M -45.4% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$500 M -$161 M -47.7% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 -$459 M -$155 M -51.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$417 M -$144 M -53% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$376 M -$133 M -54.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 -$338 M -$123 M -57.3% Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$303 M -$113 M -59.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$273 M -$109 M -66.8% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$243 M -$103 M -72.9% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$215 M -$97.3 M -82.5% Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$191 M -$91.8 M -92.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$164 M -$81.2 M -98.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$141 M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 -$118 M -$41.5 M -54.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$98.8 M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$82.3 M Jun 30, 2020 10-Q 2020-08-11
Q4 2019 -$76.3 M Dec 31, 2019 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.